论文信息 - The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients - 字舞流文

The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients

C. Ulrich | W. Haefeli | M. Gnant | W. Roth | D. Scherer | L. Paleari | T. Bachleitner-Hofmann | A. Decensi | M. Puntoni | M. Clavarezza | B. Štabuc | Marilena Petrera | S. Caviglia | Irene Maria Briata | M. Oppezzi | Silvia Caviglia | Eva Mihajlović Mislej | I. M. Briata